Innovage Holding Corp. (INNV) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Innovage Holding Corp. and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INNV
Innovage Holding Corp.
$8.98HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$12.12HealthcareDelayed quote: Oct 6, 2026, 11:40 AM EDT
Total return — INNV vs ORIC
growth of $100 · dividends reinvested · last 6yINNV -62.8% (-15.2%/yr)ORIC -63.8% (-15.6%/yr)INNV compounded faster over this window
INNV ORIC
INNV vs ORIC: by the numbers
- •ORIC is the larger company ($1.25B vs $1.22B market cap).
- •Both run net losses; ORIC's is the smaller (0.00% vs -0.26% net margin).
Metrics side by side
Valuation
| Metric | INNV | ORIC |
|---|---|---|
| Forward P/E | 20.38 | N/A |
| P/S ratio | 1.23 | N/A |
| P/B ratio | 5.17 | 3.29 |
| EV / EBITDA | 14.31 | N/A |
| FCF yield | 4.14% | N/A |
Profitability
| Metric | INNV | ORIC |
|---|---|---|
| Gross margin | 21.39% | 0.00% |
| Operating margin | 6.39% | 0.00% |
| Net margin | -0.26% | 0.00% |
| ROE | -1.08% | -36.81% |
| ROIC | 9.48% | -40.32% |
Growth (annualized)
| Metric | INNV | ORIC |
|---|---|---|
| Revenue CAGR (5Y) | 9.19% | N/A |
| Total return CAGR (5Y) | 5.55% | -8.73% |
Frequently asked
- How have INNV and ORIC total returns compared?
- Over the past 5 years, INNV delivered 5.55% and ORIC delivered -8.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Innovage ROEORIC Pharmaceuticals ROEInnovage operating marginORIC Pharmaceuticals operating marginInnovage revenue growthORIC Pharmaceuticals revenue growthInnovage free cash flowORIC Pharmaceuticals free cash flow
Innovage & ORIC Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.